Home › NDC Lookup › RxCUI directory › RxCUI 1597129

5000 MG testosterone 0.01 MG/MG Topical Gel — RxCUI 1597129

RxNorm drug concept · Semantic clinical drug
RxCUI 1597129 Semantic clinical drug · SCD ● Current RxNorm concept 19 FDA products 23 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1597129
Official name5000 MG testosterone 0.01 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astestosterone 50 MG Transdermal Gel, 5 GM; testosterone 1 % (50 MG / 5 GM) Transdermal Gel
FDA products mapped19
Package NDCs mapped23
Reported Medicaid activity (SDUD)28,698 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Testosterone gel is a hormone replacement therapy for adult men whose bodies don't produce enough testosterone on their own — a condition called hypogonadism. This can happen becau...
  • What exactly is testosterone gel used for?
  • Yes, location really matters. Testosterone gel 1.62% goes on the shoulders and upper arms only — not the abdomen, chest, genitals, armpits, or knees. Apply it to clean, dry, unbrok...
  • How do I apply it correctly, and does it matter where I put it?
📖 Read our full Testosterone Transdermal Patch guide →

🕸️ Concept Web — How 5000 MG testosterone 0.01 MG/MG Topical Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5000 MG testosterone 0.01 MG/MG Topical Gel RxCUI 1597129

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Testosterone 10379
  2. Brand names 3

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Androgel 261448
    • Testim 353016
    • Vogelxo 1539902
  3. Dose forms 10

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Testosterone Topical Gel 378070
    • Testosterone Topical Product 1164845
    • Testosterone Topical Gel [Androgel] 370440
    • Testosterone Topical Gel [Testim] 370420
    • Testosterone Topical Gel [Vogelxo] 1539904
    • Androgel Topical Product 1175588
    • Testim Topical Product 1182678
    • Vogelxo Topical Product 1539905
    • +2 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Testosterone 0.01 MG/MG SCDC · 331500
  • Testosterone Topical Gel SCDF · 378070
  • Testosterone Topical Product SCDG · 1164845

Brand-Name Concepts

📦 FDA Products & Package NDCs

19 products · 23 package NDCs
23 package NDCs map to RxCUI 1597129 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00245-0871-05 30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-08... Vogelxo Upsher-Smith Laboratories, LLC 2014-06-09
00245-0871-35 30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (024... Vogelxo Upsher-Smith Laboratories, LLC 2014-06-09
00245-0872-42 2 BOTTLE, PUMP in 1 CARTON (0245-0872-42) / 60 GEL, METERED... Vogelxo Upsher-Smith Laboratories, LLC 2014-06-09
00591-2921-02 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTL... Testosterone Actavis Pharma, Inc. 2015-12-14
00591-3216-30 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0... Testosterone Actavis Pharma, Inc. 2015-12-04
00591-3217-30 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (059... Testosterone Actavis Pharma, Inc. 2015-12-04
00591-3524-30 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-35... Testosterone Actavis Pharma, Inc. 2017-10-12
00832-1120-05 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-11... Testosterone Upsher-Smith Laboratories, LLC 2014-06-16
00832-1120-35 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (083... Testosterone Upsher-Smith Laboratories, LLC 2014-06-16
00832-1121-42 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED... Testosterone Upsher-Smith Laboratories, LLC 2014-06-16
17139-0501-02 2 BOTTLE, PUMP in 1 CARTON (17139-501-02) / 75 g in 1 BOTTL... AndroGel ASCEND Therapeutics U.S., LLC 2023-02-17
17139-0525-30 30 PACKET in 1 CARTON (17139-525-30) / 2.5 g in 1 PACKET AndroGel ASCEND Therapeutics U.S., LLC 2023-02-17
17139-0550-30 30 PACKET in 1 CARTON (17139-550-30) / 5 g in 1 PACKET AndroGel ASCEND Therapeutics U.S., LLC 2023-02-17
21922-0019-02 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET Testosterone Gel, 1% Encube Ethicals, Inc. 2021-01-10
21922-0019-47 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINE... Testosterone Gel, 1% Encube Ethicals, Inc. 2024-02-14
21922-0019-52 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET Testosterone Gel, 1% Encube Ethicals, Inc. 2024-08-12
64380-0151-02 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE P... Testosterone Strides Pharma Science Limited 2022-06-27
64380-0152-02 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PAC... Testosterone Strides Pharma Science Limited 2022-06-27
66887-0001-05 30 TUBE in 1 CARTON (66887-001-05) / 5 g in 1 TUBE Testim Endo USA, Inc. 2002-10-31
66993-0953-44 2 BOTTLE, PUMP in 1 CARTON (66993-953-44) / 88 g in 1 BOTTL... Testosterone Prasco Laboratories 2025-05-19
66993-0954-30 30 PACKET in 1 CARTON (66993-954-30) / 2.5 g in 1 PACKET Testosterone Prasco Laboratories 2025-12-01
66993-0955-30 30 PACKET in 1 CARTON (66993-955-30) / 5 g in 1 PACKET Testosterone Prasco Laboratories 2025-12-01
72162-1274-03 30 PACKET in 1 CARTON (72162-1274-3) / 5 g in 1 PACKET Testosterone Gel, 1% Bryant Ranch Prepack 2025-02-13
Observed labelers: Upsher-Smith Laboratories, LLC (6) · Actavis Pharma, Inc. (4) · ASCEND Therapeutics U.S., LLC (3) · Encube Ethicals, Inc. (3) · Prasco Laboratories (3) · Strides Pharma Science Limited (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.